Legal Opinion
ViiV Healthcare UK Ltd. v. Lupin Ltd.
District Court, D. Delaware
Decided December 17, 2013No. C.A. 11-576-RGA (CONSOLIDATED)PublishedCited by 2 opinions
1Opinion of the Court
TRIAL OPINION
ANDREWS, UNITED STATES DISTRICT JUDGE:
Plaintiffs ViiV Healthcare UK Ltd. and ViiV Healthcare Co. (collectively “ViiV”) assert U.S. Patent No. 6,417,191 (“the '191 Patent”) against Defendants Teva Pharmaceuticals, Inc. (“Teva”), Lupin Ltd., and Lupin Pharmaceuticals, Inc. (collectively “Lupin”). The '191 Patent (JX 1) is titled “Synergistic Combinations of Zidovudine, 1592U89 and 3TC.”1 (D.I.178, Ex. 1 ¶ 7). The patent issued on July 9, 2002, and expires on March 28, 2016. (Id. ¶¶ 7, 9). The named inventors are David Walter Barry and Martha Heider St. Clair. Id. ¶ 8. The patent…
2Cases cited35 opinions
- Warth v. SeldinSupreme Court of the United States · 1975
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Global-Tech Appliances, Inc. v. SEB S. A.Supreme Court of the United States · 2011
- Dsu Medical Corporation v. Jms Co., LtdCourt of Appeals for the Federal Circuit · 2006
- Eurand, Inc. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2012
30 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Impax Labs., Inc. v. Lannett Holdings Inc.District Court, D. Delaware · 2017
- Vertex Pharmaceuticals Inc. v. Lupin Limited and Lupin Pharmaceuticals, Inc.District Court, D. Delaware · 2026